Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| THRY | Thryv | $2.10 | -$1.82 | -46.43% | 3.6K | $92M | $2.06$17.46 |
| IONZ | Tidal Trust II - Defiance Daily Target 2x Short Ionq ETF | $14.30 | -$10.92 | -43.30% | 59.2K | - | $12.48$137.71 |
| EOSE | Eos Energy Enterprises | $6.74 | -$4.39 | -39.44% | 5.3M | $2.2B | $3.07$19.86 |
| ERII | Energy Recovery | $10.38 | -$5.74 | -35.61% | 173.9K | $552M | $10.22$18.32 |
| ARRY | Array Technologies | $7.26 | -$3.75 | -34.05% | 1.3M | $1.1B | $3.76$12.23 |
| DBGI | Digital Brands Group | $2.94 | -$1.40 | -32.26% | 204 | $24M | $1.77$18.00 |
| QURE | uniQure | $17.08 | -$7.79 | -31.32% | 862.1K | $1.1B | $7.76$71.50 |
| BRAI | Braiin | $17.54 | -$7.21 | -29.13% | 350 | $1.2B | $13.10$98.99 |
| AIDX | 20/20 Biolabs | $4.08 | -$1.60 | -28.17% | 4.1K | $20M | $3.67$50.00 |
| RPGL | Republic Power Group | $4.09 | -$1.41 | -25.64% | 94 | $71M | $3.62$103.80 |
| AGPU | Axe Compute | $2.02 | -$0.57 | -22.01% | 109.4K | $6.9M | $2.00$39.00 |
| WD | Walker & Dunlop | $47.57 | -$11.34 | -19.25% | 56.5K | $1.6B | $46.44$90.00 |
| TTI | TETRA Technologies | $9.06 | -$2.08 | -18.67% | 210 | $1.2B | $2.03$12.54 |
| PAYO | Payoneer Global | $4.27 | -$0.97 | -18.51% | 1.8K | $1.5B | $4.18$8.75 |
| AI | C3.ai | $8.42 | -$1.89 | -18.33% | 1.3M | $1.2B | $7.73$30.24 |
| CGTL | Creative Global Technology | $2.41 | -$0.52 | -17.75% | 343K | $62M | $0.41$6.52 |
| ACMR | ACM Research | $57.04 | -$11.43 | -16.69% | 1.1K | $3.7B | $16.82$71.65 |
| NAUT | Nautilus Biotechnology | $2.41 | -$0.48 | -16.61% | 10.7K | $306M | $0.62$3.08 |
| TXXS | Listed Funds Trust - 21Shares 2x Long Sui ETF | $5.12 | -$0.99 | -16.21% | 41.1K | - | $4.40$30.70 |
| FOUR | Shift4 Payments | $48.30 | -$9.08 | -15.82% | 326K | $3.3B | $46.26$108.50 |
| DPRO | Draganfly | $6.87 | -$1.29 | -15.81% | 201.9K | $160M | $1.63$14.40 |
| METC | Ramaco Resources | $14.93 | -$2.73 | -15.46% | 781 | $988M | $6.25$57.80 |
| CARS | Cars.com | $9.08 | -$1.66 | -15.46% | 4M | $543M | $8.86$13.97 |
| PRCT | Procept BioRobotics | $23.57 | -$4.28 | -15.36% | 429.3K | $1.3B | $19.35$66.85 |
| FSK | Fs Kkr Capital | $11.29 | -$2.04 | -15.28% | 782.4K | $3.2B | $10.87$23.53 |
| ATOM | Atomera | $5.21 | -$0.92 | -15.01% | 4.2K | $165M | $1.89$7.73 |
| CHE | Chemed | $396.63 | -$69.97 | -15.00% | 821.6K | $5.6B | $385.00$623.61 |
| MIRM | Mirum Pharmaceuticals | $92.42 | -$16.20 | -14.91% | 113.5K | $4.8B | $36.88$109.28 |
| BBSI | Barrett Business Services | $26.83 | -$4.64 | -14.74% | 1M | $688M | $25.33$49.65 |
| GDC | Gd Culture Group | $3.58 | -$0.55 | -13.32% | 64.5K | $205M | $1.60$9.92 |
Related Articles
Featured Article
Can C3 AI Finally Earn Back Investor Confidence?
Rick Orford|Feb 12, 2026
C3 AI stock is volatile, controversial, and risky, but the payoff could be massive if execution finally matches the vision.
Is Mirum Pharmaceuticals on a Strong Path to Profitability?
Prosper Junior Bakiny|Jan 31, 2026
The drugmaker is doing nearly everything else right.
1 Fintech Stock Set to Rebound in 2026
Todd Shriber|Jan 28, 2026
This fintech stock slumped last year, but its darkest days may be behind it.
Is Mirum Pharmaceuticals About to Soar in 2026?
Keith Speights|Jan 27, 2026
The future looks bright for this high-flying biotech stock.
3 Top Growth Stocks to Buy in the First Half of 2026
Keith Speights|Jan 13, 2026
Don't wait too long to make a decision on these three stocks.
Should You Buy C3.ai Stock After Its 55% Drop in 2025? Here's What Wall Street Thinks.
Anthony Di Pizio|Dec 15, 2025
There is a lot of uncertainty surrounding C3.ai heading into the new year.
Is C3.ai Stock a Buy Now?
Harsh Chauhan|Dec 11, 2025
Should investors start buying this AI software stock after its latest quarterly report?
Prediction: This Stock Has Soared Nearly 70% in 2025 and Will Be an Even Bigger Winner in 2026
Keith Speights|Dec 3, 2025
Mirum Pharmaceuticals is a mid-cap biotech stock to keep your eyes on.
Should You Buy C3.ai Stock Before the Huge Investor Update?
Parkev Tatevosian, CFA|Nov 25, 2025
Investors are hopeful that C3.ai can achieve similar success to Palantir.
Massive News: Why Analysts Still See 167% Upside for C3.ai Stock
Rick Orford|Nov 19, 2025
C3.ai's stock has fallen hard -- but analysts still see triple-digit upside. Discover whether this beaten-down AI pioneer could be 2026's biggest turnaround story.
